Drug Patents owned by Alcon Labs Inc

1. Drug name - PATADAY ONCE DAILY RELIEF

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8791154 ALCON LABS INC High concentration olopatadine ophthalmic composition May, 2032

(9 years from now)

US9533053 ALCON LABS INC High concentration olopatadine ophthalmic composition May, 2032

(9 years from now)

Drugs and Companies using OLOPATADINE HYDROCHLORIDE ingredient

Treatment: Treatment of ocular itching associated with allergic conjunctivitis

Dosage: SOLUTION/DROPS;OPHTHALMIC

More Information on Dosage
Strength Dosage Availability
EQ 0.7% BASE SOLUTION/DROPS;OPHTHALMIC Over the counter

2. Drug name - SIMBRINZA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9421265 ALCON LABS INC Aqueous pharmaceutical compositions containing borate-polyol complexes Jun, 2030

(7 years from now)

US9044484 ALCON LABS INC Aqueous pharmaceutical compositions containing borate-polyol complexes Oct, 2030

(8 years from now)

Drugs and Companies using BRIMONIDINE TARTRATE; BRINZOLAMIDE ingredient

Treatment: NA

Dosage: SUSPENSION/DROPS;OPHTHALMIC

More Information on Dosage
Strength Dosage Availability
0.2%;1% SUSPENSION/DROPS;OPHTHALMIC Prescription

availability in other generic markets.

Click on the highlighted region to filter.